Aguzzi A, O'Connor T (March 2010). "Protein aggregation diseases: pathogenicity and therapeutic perspectives". Nature Reviews. Drug Discovery. 9 (3): 237–248. doi:10.1038/nrd3050. PMID20190788. S2CID5756683.
Stefani M, Dobson CM (November 2003). "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution". Journal of Molecular Medicine. 81 (11): 678–699. doi:10.1007/s00109-003-0464-5. PMID12942175. S2CID23544974.
Berke SJ, Paulson HL (June 2003). "Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration". Current Opinion in Genetics & Development. 13 (3): 253–261. doi:10.1016/S0959-437X(03)00053-4. PMID12787787.
Tyedmers J, Mogk A, Bukau B (November 2010). "Cellular strategies for controlling protein aggregation". Nature Reviews. Molecular Cell Biology. 11 (11): 777–788. doi:10.1038/nrm2993. PMID20944667. S2CID22449895.
Stadtman ER, Levine RL (December 2003). "Free radical-mediated oxidation of free amino acids and amino acid residues in proteins". Amino Acids. 25 (3–4): 207–218. doi:10.1007/s00726-003-0011-2. PMID14661084. S2CID26844881.
Wan W, Zeng L, Jin W, Chen X, Shen D, Huang Y, et al. (December 2021). "A Solvatochromic Fluorescent Probe Reveals Polarity Heterogeneity upon Protein Aggregation in Cells". Angewandte Chemie. 60 (49): 25865–25871. doi:10.1002/anie.202107943. PMID34562048. S2CID237626399.
Wan W, Zeng L, Jin W, Chen X, Shen D, Huang Y, et al. (December 2021). "A Solvatochromic Fluorescent Probe Reveals Polarity Heterogeneity upon Protein Aggregation in Cells". Angewandte Chemie. 60 (49): 25865–25871. doi:10.1002/anie.202107943. PMID34562048. S2CID237626399.
Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. (September 2001). "The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation". Nature Neuroscience. 4 (9): 887–893. doi:10.1038/nn0901-887. PMID11528419. S2CID13516479.
Soto C (January 2003). "Unfolding the role of protein misfolding in neurodegenerative diseases". Nature Reviews. Neuroscience. 4 (1): 49–60. doi:10.1038/nrn1007. PMID12511861. S2CID205499427.
Vázquez-Rey M, Lang DA (July 2011). "Aggregates in monoclonal antibody manufacturing processes". Biotechnology and Bioengineering. 108 (7): 1494–1508. doi:10.1002/bit.23155. PMID21480193. S2CID33285577.
Aguzzi A, O'Connor T (March 2010). "Protein aggregation diseases: pathogenicity and therapeutic perspectives". Nature Reviews. Drug Discovery. 9 (3): 237–248. doi:10.1038/nrd3050. PMID20190788. S2CID5756683.
Stefani M, Dobson CM (November 2003). "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution". Journal of Molecular Medicine. 81 (11): 678–699. doi:10.1007/s00109-003-0464-5. PMID12942175. S2CID23544974.
Berke SJ, Paulson HL (June 2003). "Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration". Current Opinion in Genetics & Development. 13 (3): 253–261. doi:10.1016/S0959-437X(03)00053-4. PMID12787787.
Tyedmers J, Mogk A, Bukau B (November 2010). "Cellular strategies for controlling protein aggregation". Nature Reviews. Molecular Cell Biology. 11 (11): 777–788. doi:10.1038/nrm2993. PMID20944667. S2CID22449895.
Stadtman ER, Levine RL (December 2003). "Free radical-mediated oxidation of free amino acids and amino acid residues in proteins". Amino Acids. 25 (3–4): 207–218. doi:10.1007/s00726-003-0011-2. PMID14661084. S2CID26844881.
Wan W, Zeng L, Jin W, Chen X, Shen D, Huang Y, et al. (December 2021). "A Solvatochromic Fluorescent Probe Reveals Polarity Heterogeneity upon Protein Aggregation in Cells". Angewandte Chemie. 60 (49): 25865–25871. doi:10.1002/anie.202107943. PMID34562048. S2CID237626399.
Wan W, Zeng L, Jin W, Chen X, Shen D, Huang Y, et al. (December 2021). "A Solvatochromic Fluorescent Probe Reveals Polarity Heterogeneity upon Protein Aggregation in Cells". Angewandte Chemie. 60 (49): 25865–25871. doi:10.1002/anie.202107943. PMID34562048. S2CID237626399.
Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. (September 2001). "The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation". Nature Neuroscience. 4 (9): 887–893. doi:10.1038/nn0901-887. PMID11528419. S2CID13516479.
Soto C (January 2003). "Unfolding the role of protein misfolding in neurodegenerative diseases". Nature Reviews. Neuroscience. 4 (1): 49–60. doi:10.1038/nrn1007. PMID12511861. S2CID205499427.
Vázquez-Rey M, Lang DA (July 2011). "Aggregates in monoclonal antibody manufacturing processes". Biotechnology and Bioengineering. 108 (7): 1494–1508. doi:10.1002/bit.23155. PMID21480193. S2CID33285577.
Aguzzi A, O'Connor T (March 2010). "Protein aggregation diseases: pathogenicity and therapeutic perspectives". Nature Reviews. Drug Discovery. 9 (3): 237–248. doi:10.1038/nrd3050. PMID20190788. S2CID5756683.
Stefani M, Dobson CM (November 2003). "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution". Journal of Molecular Medicine. 81 (11): 678–699. doi:10.1007/s00109-003-0464-5. PMID12942175. S2CID23544974.
Wan W, Zeng L, Jin W, Chen X, Shen D, Huang Y, et al. (December 2021). "A Solvatochromic Fluorescent Probe Reveals Polarity Heterogeneity upon Protein Aggregation in Cells". Angewandte Chemie. 60 (49): 25865–25871. doi:10.1002/anie.202107943. PMID34562048. S2CID237626399.
Gregersen N, Bolund L, Bross P (October 2005). "Protein misfolding, aggregation, and degradation in disease". Molecular Biotechnology. 31 (2): 141–150. doi:10.1385/MB:31:2:141. PMID16170215. S2CID36403914.
Wan W, Zeng L, Jin W, Chen X, Shen D, Huang Y, et al. (December 2021). "A Solvatochromic Fluorescent Probe Reveals Polarity Heterogeneity upon Protein Aggregation in Cells". Angewandte Chemie. 60 (49): 25865–25871. doi:10.1002/anie.202107943. PMID34562048. S2CID237626399.
Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. (September 2001). "The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation". Nature Neuroscience. 4 (9): 887–893. doi:10.1038/nn0901-887. PMID11528419. S2CID13516479.
Soto C (January 2003). "Unfolding the role of protein misfolding in neurodegenerative diseases". Nature Reviews. Neuroscience. 4 (1): 49–60. doi:10.1038/nrn1007. PMID12511861. S2CID205499427.
Vázquez-Rey M, Lang DA (July 2011). "Aggregates in monoclonal antibody manufacturing processes". Biotechnology and Bioengineering. 108 (7): 1494–1508. doi:10.1002/bit.23155. PMID21480193. S2CID33285577.